2 Matching Annotations
  1. Oct 2021
  2. www.bmj.com www.bmj.com
    Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds
    1
    1. Marlene_Wulf 31 Oct 2021

      Mahase, E. (2021). Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds. BMJ, 375, n2623. https://doi.org/10.1136/bmj.n2623

      is:article lang:en COVID-19 blood cancer patient antibody Delta variant two vaccine doses study lower level neutralising
    Visit annotations in context

    Tags

    Annotators

    URL

    bmj.com/content/375/bmj.n2623
  3. Jul 2020
  4. doi.org doi.org
    https://doi.org/10.1101/2020.06.23.20136200
    1
    1. ErikStuchly 05 Jul 2020

      Su, Q., Hu, J., Lin, H., Zhang, Z., Zhu, E. C., Zhang, C., Wang, D., Gao, Z., & Cao, B. (2020). Prevalence and risks of severe events for cancer patients with COVID-19 infection: A systematic review and meta-analysis. MedRxiv, 2020.06.23.20136200. https://doi.org/10.1101/2020.06.23.20136200

      is:article lang:en COVID-19 cancer patient severe event risk systematic review meta-analysis epidemiology hospitalization mortality public health
    Visit annotations in context

    Tags

    Annotators

    URL

    doi.org/10.1101/2020.06.23.20136200